King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)

KG 22.00

-6.5%

3:02 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: betone who wrote (46)	11/16/2001 1:05:17 PM
From: Jim Oravetz	of 61

07:43 ET King Pharms (KG) 37.99: Goldman Sachs upgrades to REC LIST from Mkt Outperform based on attractive valuation and strong fundamentals. KG ranks #1 in Goldman's universe for upward earnings revisions for 2001 (20%) and 2002 (29%). Sees trend of 14 positive earnings surprises continuing. Firm's 12-month target remains $56. Briefing.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next